COURTNEY CROOK: Open Payments
NPI 1952134942 · WOODSTOCK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,514 in 99 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $114 · 2025 $1,514
Food & beverage: $1,514
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 27 | $295 |
| ABBVIE INC. | 18 | $221 |
| AstraZeneca Pharmaceuticals LP | 5 | $212 |
| Novo Nordisk Inc | 14 | $204 |
| Lilly USA, LLC | 10 | $156 |
| Esperion Therapeutics, Inc. | 5 | $91 |
| Medtronic, Inc. | 4 | $65 |
| GlaxoSmithKline, LLC. | 4 | $63 |
| Amgen Inc. | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
Products named: NURTEC ODT, BREZTRI, Ozempic, ELIQUIS, NEXLETOL, VRAYLAR, MOUNJARO, UBRELVY.
Industry payments across GA — which companies pay providers there.
